Chronic Lung Disease of Prematurity Active Not Recruiting Phase 2 Trials for Furosemide (DB00695)

Also known as: Bronchopulmonary Dysplasia / Dysplasia, Bronchopulmonary / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02527798Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)Other